ibr 140 mg Pill - white capsule/oblong, 22mm
Generic Name: ibrutinib
Pill with imprint ibr 140 mg is White, Capsule/Oblong and has been identified as Imbruvica 140 mg. It is supplied by Pharmacyclics Inc.
Imbruvica is used in the treatment of Chronic Lymphocytic Leukemia; Waldenström Macroglobulinemia; Graft Versus Host Disease and belongs to the drug class BTK inhibitors. There is positive evidence of human fetal risk during pregnancy. Imbruvica 140 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for ibr 140 mg
Imbruvica
- Generic Name
- ibrutinib
- Imprint
- ibr 140 mg
- Strength
- 140 mg
- Color
- White
- Size
- 22.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- BTK inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Pharmacyclics Inc
- National Drug Code (NDC)
- 57962-0140
More about Imbruvica (ibrutinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (66)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: BTK inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.